⏱ 1 min read
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange. Ever since the heady ‘Green’ IPO rush of the late 2010s and early 2020s, MSOS’ stocks tracked by New Cannabis Ventures have plummeted -87.1% in value, while the wider Global Index fell by -85.2% over the same period. Effectively banned from listing on US blue chip exchanges like Nasdaq, any US operators willing…
Explore all articles: CBD and hemp products
